In recent years, therapeutic peptides have been developed for the treatment of several diseases such as cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders, among others. Further research has been done to develop a rich pipeline of novel peptides as a result of their efficacy treating a huge array of conditions, and the global peptide therapeutics market is expected to reach a value of US$23.7B by 2020*

SMi’s 3rd annual Peptides event provides the perfect platform to discuss the latest innovations and development in the peptides industry and explore a number of pressing issues such as the use of Cell Penetrating Peptides (CPP), the challenges involved with oral peptides and many more.